http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017128428-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc018052906c6c52786ea74b48ef6d84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_384d7bc5ff6035f03660f56fbfa33947
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
filingDate 2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f24fdcc5e1e370789d6f33135e8952c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_128467ad951f22e037d2140ee47b1142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a16bc8e2bc8293d17d91350ff58a14d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36ee6e9bf4e54cdcac7051d6aca978fe
publicationDate 2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2017128428-A1
titleOfInvention Centrally acting acetylcholinesterase inhibitors for the prevention and/or treatment of chemically induced neuropathies and the symptoms thereof, and corresponding compositions, uses, methods and kit
abstract The invention relates to a composition for using in the treatment and/or prevention of chemically induced neuropathies, said composition comprising at least one reversible centrally acting acetylcholinesterase inhibitor. The invention also relates to the corresponding methods, uses and kit.
priorityDate 2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7749575-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6638534-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5100901-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136123990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229152033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229152041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129096312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID340226190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227407239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID969462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID249332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135402009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18004597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6711468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233793271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342

Total number of triples: 87.